Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Shandong Xinhua Pharmaceutical Company Limited Class H ( (HK:0719) ) has provided an announcement.
Shandong Xinhua Pharmaceutical Company Limited has announced proposed amendments to its Articles of Association following an increase in its issued share capital due to the exercise of options under its Share Option Scheme. Additionally, the company has absorbed Ronghua (Zibo) Property Services Co., Ltd., expanding its business scope to include property management and real estate rental services. These changes necessitate revisions to the company’s Articles of Association, which will be subject to shareholder approval at a general meeting.
More about Shandong Xinhua Pharmaceutical Company Limited Class H
Shandong Xinhua Pharmaceutical Company Limited is a joint stock company based in the People’s Republic of China. It operates in the pharmaceutical industry, focusing on the production and distribution of pharmaceutical products. The company is listed on the Stock Exchange of Hong Kong.
YTD Price Performance: -0.69%
Average Trading Volume: 3,436,257
Technical Sentiment Signal: Strong Sell
Current Market Cap: HK$9.16B
Learn more about 0719 stock on TipRanks’ Stock Analysis page.